Investigation of the Effects of Whole Body Vibration Application on Muscle Functional Level, Physical Fitness and Respiratory Parameters After Bariatric Surgery
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
The aim of this study was to investigate the effects of whole body vibration on muscle functional level, physical fitness and respiratory parameters after bariatric surgery. Hypotheses of the study: H1: TVV after bariatric surgery has an effect on the functional level of the muscle. H2: TVV after bariatric surgery has an effect on physical fitness. H3: TVV after bariatric surgery has an effect on respiratory parameters. H4: TVV after bariatric surgery has an effect on quality of life. H5: TVV after bariatric surgery has an effect on body composition. H6: TVV after bariatric surgery has an effect on biochemical parameters. Patients will be divided into 3 randomized controlled groups. Whole body vibration application group, resistance exercise group and control group. The whole body vibration group will exercise on the device 3 days a week. Resistance exercise group will exercise with resistance band 3 days a week. All exercises will last 6 weeks. The whole body vibration, resistance exercise and control groups will be recommended to walk 7 days a week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2025
CompletedFirst Posted
Study publicly available on registry
May 22, 2026
CompletedStudy Start
First participant enrolled
May 30, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
Study Completion
Last participant's last visit for all outcomes
September 1, 2026
May 22, 2026
May 1, 2026
1 month
June 16, 2025
May 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Muscle Ultrasound
Measurements will be made using a 5-12 MHz probe. Muscle fascicle lengths, muscle thickness and pennate angles are measured. Sarcopenia mainly affects the lower extremity muscles more. Quadriceps muscle is one of the basic muscles that enable us to perform daily life activities such as walking and standing. The functionality of the quadriceps muscle allows us to have information about the quality of life of individuals. The gastrocnemius muscle is also one of the methods used to determine sarcopenic obesity by ultrasound (Deniz et al., 2020; Minetto et al., 2016; Perkisas et al., 2021). In a study conducted by Li et al. in 2020 with 179 geriatric individuals, the biceps brachii muscles of the participants were measured by ultrasound. In the study, it was observed that the cross-sectional area of the biceps brachii muscle was significantly reduced in sarcopenic elderly compared to non-sarcopenic elderly (Li et al., 2020).
6 weeks
Muscle Strength Measurement
Peripheral muscle strength of shoulder abductor and adductor, shoulder flexor, extensor, elbow flexor and extensor, hip flexor, extensor, abductor and adductor, knee flexor and extensor muscles will be measured with a portable myometer (Model 01165, Lafayette, IN, USA). Hand grip strength will be measured with a hand dynamometer (Jamar, Nottinghamshire, England) in a sitting position, elbow flexed 90 degrees, wrist neutral. The measurements will be repeated three times for the right and left side and the best of the values obtained will be recorded in Newton (N) (Hébert et al., 2011).
6 weeks
Elasticity Evaluation of Muscle
The tonus of quadriceps, gastrocnemius and biceps brachii muscles will be measured with MyotonPro™ device (Myoton AS, Talin, Estonia). The most bulging part of the muscle will be marked with a skin marker pen and the device will be placed perpendicular to the muscle. During the test, a 0.4N impulse is applied from the device to the skin with a force of 0.18N and a duration of 15 msec. Elasticity values (ms) of the muscle will be recorded on the screen of the device (Aird et al., 2012). The assessment point and position of the muscles will be measured according to the positions and criteria recommended on the Myoton®PRO official website (https://www.myoton.com/applications).
6 weeks
Respiratory Muscle Strength Assessment
In the respiratory muscle strength assessment, the maximum inspiratory intraoral pressure (IMP) and maximum expiratory intraoral pressure (MEP) of the patients will be measured using a portable, electronic oral pressure measuring device, and the values will be recorded in cmH2O. MIP is the intraoral pressure measured during maximum inspiration against a valve closing the airway. For measurement, the subject is made to expire maximally and at the end of this, the airway is closed with a valve and the subject is asked to inspire maximally and maintain this for '1-3' seconds. MEP is the intraoral pressure measured during maximal expiration against a valve closing the airway. In MEP measurement, after the person performs maximal inspiration, the person is asked to perform maximal expiration for '1-3' seconds against the closed airway. The best of the three measurements will be selected. It will be expressed as a percentage of normal reference values calculated according to age and gender.
6 weeks
Respiratory Muscle Endurance
In the dynamic method, peak inspiratory flow rate (PIF) and respiratory muscle strength index (S-index) will be assessed using the portable POWERbreathe K5 device (PowerBreathe K5, HaB International Ltd, Warwickshire, UK). Patients will perform at least 10 consecutive speed-dependent maneuvers (4.5 seconds between inspirations) in two different phases of the assessment sequence. Respiratory muscle endurance will be assessed using the POWERbreathe Classic respiratory muscle training device (PowerBreathe International Ltd, Warwickshire, UK) with an increasing workload test. The test will start with 30% of the MIP and the patient will be asked to breathe deeply with this workload for 2 minutes. For patients who have completed 2 minutes, the workload will be increased by 10% per minute. The final workload sustained for at least 1 minute will be recorded (Woszezenki et al., 2017, Silva et al., 2018).
6 weeks
Pulmonary Function Test
In the pulmonary function test, patients' forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), the ratio of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC), peak flow rate (PEF) will be measured with a portable spirometer. Pulmonary function test parameters will be expressed in liters and as a percentage of the expected value. Pulmonary function test will be performed with a spirometer (Cosmed Pony FX, Italy) according to ATS/ ERS criteria. Against the risk of infection, appropriate sterilization method recommended by the guideline, disposable, personalized mouthpieces and filters will be used (Ucok et al., 2010).
6 weeks
Cardiopulmonary Exercise Test
In our study, CPET will be performed with a treadmill. Modified Bruce protocol will be applied. All participants will be informed about the device before starting the test. Situations that may require people to terminate the test will be explained. During the test, people will breathe in and out with a mask with a gas analyzer attached at the end so that the amount of oxygen they take in and carbon dioxide they exhale can be measured. Ventilation parameters will be obtained by analyzing and measuring the gases collected by gas analyzers and flow meters in each breath. Heart rate and ECG will be monitored during KPET. The test will be terminated if the person states that he/she cannot continue the exercise for any reason or if there are indications to terminate the exercise. During the test, VO2max, RER, HR, VO2/HR, maximum time, VE/VO2, VE/VCO2, VD/VT, VE, BF, BR, paCO2, VO2/kg, values will be recorded.
6 weeks
Stiffness of Muscle
Description: The tonus of quadriceps, gastrocnemius and biceps brachii muscles will be measured with MyotonPro™ device (Myoton AS, Talin, Estonia). The most bulging part of the muscle will be marked with a skin marker pen and the device will be placed perpendicular to the muscle. During the test, a 0.4N impulse is applied from the device to the skin with a force of 0.18N and a duration of 15 msec. Stiffness (N/m) value of the muscle will be recorded on the screen of the device (Aird et al., 2012). The assessment point and position of the muscles will be measured according to the positions and criteria recommended on the Myoton®PRO official website (https://www.myoton.com/applications). Time Frame: 6 weeks
6 weeks
Tonus Evaluation of Muscle
Description: The tonus of quadriceps, gastrocnemius and biceps brachii muscles will be measured with MyotonPro™ device (Myoton AS, Talin, Estonia). The most bulging part of the muscle will be marked with a skin marker pen and the device will be placed perpendicular to the muscle. During the test, a 0.4N impulse is applied from the device to the skin with a force of 0.18N and a duration of 15 msec. Tonus (Hz) value of the muscle will be recorded on the screen of the device (Aird et al., 2012). The assessment point and position of the muscles will be measured according to the positions and criteria recommended on the Myoton®PRO official website (https://www.myoton.com/applications). Time Frame: 6 weeks
6 weeks
Secondary Outcomes (3)
Biochemical Analyses
6 weeks
Body Composition Analysis
6 weeks
Assessment of Quality of Life
6 weeks
Study Arms (3)
intervention group- resistance exercise
EXPERIMENTALThe resistance exercise training group will be given resistance exercise with theraband for 6 weeks in addition to the conventional physiotherapy program. The exercise protocol will be performed 3 days a week, 1 time a day, 1 day supervised. The evaluation sessions of the individuals will be face to face. Sessions will start with a 5-minute warm-up exercise, resistance exercise protocol will be applied, and will end with a 5-minute cool-down exercise. Rest periods of 2-3 minutes will be given between sets. Before and after each exercise, heart rate, blood pressure, SpO2, dyspnea and fatigue values will be measured according to the Modified Borg Scale. They will be asked to be between 4-6 (moderate) according to the scale during the exercise. After finding 1 RM of the individuals, 50% of this value will be taken for exercise loads between 0-2 weeks. According to the corresponding value of this value in the elastic resistance band, the appropriate band color will be selected and the per
intervention group- whole body vibration
EXPERIMENTALThe WBV training group will be given exercises on the WBV device in addition to the conventional physiotherapy program. The exercise protocol will be performed face to face, 3 days a week, 1 time a day for 6 weeks. Individuals will be evaluated and exercise sessions will be conducted face to face. Exercise sessions will be performed under the control of a physiotherapist and each patient's heart rate, fatigue perception, dyspnea perception and saturation will be monitored. Individuals will be asked to report any negative experiences during or after the application. Exercises will be practiced before the application on the device. Before and after each exercise, heart rate, blood pressure, SpO2, dyspnea and fatigue values will be measured according to the Modified Borg Scale. They will be asked to be between 4-6 (moderate level) according to the scale during the exercise. At the end of the 2nd and 4th week, if dyspnea and fatigue do not develop in the person and the measured values are
control group
ACTIVE COMPARATORIndividuals will be informed about what they should do after bariatric surgery, what they should do during the treatment process and physical activity, they will be advised to walk regularly for 30 minutes a day, 7 days a week and they will be informed about the things to pay attention during walking. Patients in the control group will be asked to keep a diary, write down their vital signs and the extent to which they perform the exercise recommendation of 30 minutes a day, 7 days a week on a weekly basis. Patients in this group will be called regularly on a weekly basis and the information they keep in the diary will be requested and recorded.
Interventions
The resistance exercise training group will be given resistance exercise with theraband for 6 weeks in addition to the conventional physiotherapy program. The exercise protocol will be performed 3 days a week, 1 time a day, 1 day supervised. The evaluation sessions of the individuals will be face to face. Sessions will start with a 5-minute warm-up exercise, resistance exercise protocol will be applied, and will end with a 5-minute cool-down exercise.
The WBV training group will be given exercises on the WBV device in addition to the conventional physiotherapy program. The exercise protocol will be performed face to face, 3 days a week, 1 time a day for 6 weeks. Individuals will be evaluated and exercise sessions will be conducted face to face. Exercise sessions will be performed under the control of a physiotherapist and each patient's heart rate, fatigue perception, dyspnea perception and saturation will be monitored. Individuals will be asked to report any negative experiences during or after the application.
Individuals will be informed about what they should do after bariatric surgery, what they should do during the treatment process and physical activity, they will be advised to walk regularly for 30 minutes a day, 7 days a week and they will be informed about the things to pay attention during walking.
Eligibility Criteria
You may qualify if:
- Having undergone bariatric surgery, At least 6 weeks have passed since bariatric surgery, Being between the ages of 18-65, Being diagnosed with obesity and having a BMI\>35, There is no obstacle that restricts exercise
You may not qualify if:
- Acute hernia, Thromboembolism, Steroid use, Cardiovascular, neurological, orthopedic disease, Presence of knee or hip prosthesis, History of non-traumatic fracture, Presence of pacemaker, Malignancy, Presence of kidney, liver or thyroid disease, Presence of arrhythmia, Pregnancy status, Presence of kidney stones, Presence of epilepsy, Presence of migraine, Presence of organ failure, Presence of acute infection, History of smoking, Presence of respiratory system disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kirsehir Ahi Evran Universitesilead
- Istinye Universitycollaborator
Related Publications (19)
Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK, Neufer PD. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J. 2001 Dec;15(14):2748-50. doi: 10.1096/fj.01-0507fje. Epub 2001 Oct 29.
PMID: 11687509RESULTNecking LE, Lundstrom R, Lundborg G, Thornell LE, Friden J. Skeletal muscle changes after short term vibration. Scand J Plast Reconstr Surg Hand Surg. 1996 Jun;30(2):99-103. doi: 10.3109/02844319609056390.
PMID: 8815978RESULTRoelants M, Delecluse C, Goris M, Verschueren S. Effects of 24 weeks of whole body vibration training on body composition and muscle strength in untrained females. Int J Sports Med. 2004 Jan;25(1):1-5. doi: 10.1055/s-2003-45238.
PMID: 14750005RESULTSheng B, Truong K, Spitler H, Zhang L, Tong X, Chen L. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis. Obes Surg. 2017 Oct;27(10):2724-2732. doi: 10.1007/s11695-017-2866-4.
PMID: 28801703RESULTVissers D, Verrijken A, Mertens I, Van Gils C, Van de Sompel A, Truijen S, Van Gaal L. Effect of long-term whole body vibration training on visceral adipose tissue: a preliminary report. Obes Facts. 2010;3(2):93-100. doi: 10.1159/000301785. Epub 2010 Apr 7.
PMID: 20484941RESULTZaki ME. Effects of whole body vibration and resistance training on bone mineral density and anthropometry in obese postmenopausal women. J Osteoporos. 2014;2014:702589. doi: 10.1155/2014/702589. Epub 2014 Jun 18.
PMID: 25136473RESULTHuck CJ. Effects of supervised resistance training on fitness and functional strength in patients succeeding bariatric surgery. J Strength Cond Res. 2015 Mar;29(3):589-95. doi: 10.1519/JSC.0000000000000667.
PMID: 25226310RESULTHong SH, Choi KM. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. Int J Mol Sci. 2020 Jan 13;21(2):494. doi: 10.3390/ijms21020494.
PMID: 31941015RESULTGuazzi M, Arena R, Halle M, Piepoli MF, Myers J, Lavie CJ. 2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J. 2018 Apr 7;39(14):1144-1161. doi: 10.1093/eurheartj/ehw180.
PMID: 27141094RESULTGoto K, Takamatsu K. Hormone and lipolytic responses to whole body vibration in young men. Jpn J Physiol. 2005 Oct;55(5):279-84. doi: 10.2170/jjphysiol.RP000305. Epub 2005 Nov 8.
PMID: 16271160RESULTGloeckl R, Heinzelmann I, Baeuerle S, Damm E, Schwedhelm AL, Diril M, Buhrow D, Jerrentrup A, Kenn K. Effects of whole body vibration in patients with chronic obstructive pulmonary disease--a randomized controlled trial. Respir Med. 2012 Jan;106(1):75-83. doi: 10.1016/j.rmed.2011.10.021. Epub 2011 Nov 21.
PMID: 22104540RESULTFeland JB, Stevenson DL, Hunter I, Hopkins JT, Cochrane DJ. Acute effect of whole-body vibration on electromechanical delay and vertical jump performance. J Musculoskelet Neuronal Interact. 2021 Sep 1;21(3):373-378.
PMID: 34465676RESULTDi Giminiani R, Rucci N, Capuano L, Ponzetti M, Aielli F, Tihanyi J. Individualized Whole-Body Vibration: Neuromuscular, Biochemical, Muscle Damage and Inflammatory Acute Responses. Dose Response. 2020 Jun 29;18(2):1559325820931262. doi: 10.1177/1559325820931262. eCollection 2020 Apr-Jun.
PMID: 32647498RESULTDeniz O, Cruz-Jentoft A, Sengul Aycicek G, Unsal P, Esme M, Ucar Y, Burkuk S, Sendur A, Yavuz BB, Cankurtaran M, Halil M. Role of Ultrasonography in Estimating Muscle Mass in Sarcopenic Obesity. JPEN J Parenter Enteral Nutr. 2020 Nov;44(8):1398-1406. doi: 10.1002/jpen.1830. Epub 2020 Apr 28.
PMID: 32342544RESULTDaniels P, Burns RD, Brusseau TA, Hall MS, Davidson L, Adams TD, Eisenman P. Effect of a randomised 12-week resistance training programme on muscular strength, cross-sectional area and muscle quality in women having undergone Roux-en-Y gastric bypass. J Sports Sci. 2018 Mar;36(5):529-535. doi: 10.1080/02640414.2017.1322217. Epub 2017 May 3.
PMID: 28467737RESULThttps://www.researchgate.net/publication/367638746_THE_EFFECT_OF_6-WEEKS_WHOLE_BODY_VIBRATION_ON_MUSCULAR_PERFORMANCE_ON_YOUNG_NON-COMPETITIVE_FEMALE_ARTISTIC_GYMNASTS
RESULTBlanks AM, Rodriguez-Miguelez P, Looney J, Tucker MA, Jeong J, Thomas J, Blackburn M, Stepp DW, Weintraub NJ, Harris RA. Whole body vibration elicits differential immune and metabolic responses in obese and normal weight individuals. Brain Behav Immun Health. 2019 Nov 14;1:100011. doi: 10.1016/j.bbih.2019.100011. eCollection 2020 Jan.
PMID: 38377415RESULTBarazzoni R, Bischoff S, Boirie Y, Busetto L, Cederholm T, Dicker D, Toplak H, Van Gossum A, Yumuk V, Vettor R. Sarcopenic Obesity: Time to Meet the Challenge. Obes Facts. 2018;11(4):294-305. doi: 10.1159/000490361. Epub 2018 Jul 18.
PMID: 30016792RESULTAird L, Samuel D, Stokes M. Quadriceps muscle tone, elasticity and stiffness in older males: reliability and symmetry using the MyotonPRO. Arch Gerontol Geriatr. 2012 Sep-Oct;55(2):e31-9. doi: 10.1016/j.archger.2012.03.005. Epub 2012 Apr 13.
PMID: 22503549RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
June 16, 2025
First Posted
May 22, 2026
Study Start (Estimated)
May 30, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
May 22, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share